ARTICLE | Company News
Pfizer pharmaceuticals news
January 19, 2009 8:00 AM UTC
Pfizer will reduce headcount by 5-8% in its Pfizer Global Research and Development (PGRD) division as part of its previously announced efforts to focus R&D on oncology, Alzheimer's disease (AD), schiz...